RSV rapid antigen testing (Ag RDT) in primary care reduces inappropriate antibiotic prescribing
Published on 2026-03-10 12:28:04 by giendi
🦠New JAMA Study: RSV Rapid Testing Cuts Unnecessary Antibiotic Use in Young Children A new JAMA Network Open investigation offers compelling evidence that RSV rapid antigen testing in primary care meaningfully reduces inappropriate antibiotic prescribing for infants and toddlers with viral lower respiratory tract infections. In a cohort of 256 children aged 9–36 months, researchers found that: • RSV-positive children were prescribed far fewer antibiotics than RSV-negative children. • Implementing RSV Ag RDTs reduced antibiotic use by 40–50% compared with matched untested cohorts. • When RSV was confirmed, the reduction was even stronger (RR as low as 0.33). • Importantly, reduced prescribing did not increase ED visits or hospitalizations, reinforcing the safety of test-guided management. This study reinforces what many clinicians have long suspected: rapid viral diagnostics are essential to antimicrobial stewardship, especially in community pediatrics, where diagnostic uncertainty often drives unnecessary antibiotic use. As RSV immunoprophylaxis expands and respiratory testing becomes more accessible, the combination of prevention + rapid diagnostics will reshape how pediatric VLRTIs are managed.
📘 GRN IVD Consulting: Point of Care Market Intelligence for Respiratory Testing Our Point of Care Market Report provides deep insight into: • RSV, flu, and COVID-19 testing trends across primary care, urgent care, and ED settings • Platform-level competitive dynamics (molecular, antigen, multiplex) • Clinical guideline alignment and stewardship implications • Market sizing, growth forecasts, and channel strategy • Evidence-based positioning for manufacturers and investors As rapid testing becomes central to stewardship and clinical decision-making, diagnostics companies need clarity on where the market is heading. GRN IVD Consulting delivers the strategic intelligence to stay ahead. Register and log in for further information.